arrow
返回
A

Aude Fléchon

unicancer

54H指数
581论文数
2.5W被引数
收录论文 130
发表时间
Nivolumab in Metastatic Clear-cell Renal Cell Carcinoma: An Integrative Biomarker Analysis from the NIVOREN GETUG-AFU 26 Phase 2 Study转移性透明细胞肾细胞癌中的Nivolumab: 来自NIVOREN getug-afu 26 2期研究的综合生物标志物分析
err2025-11-11
err0
PREAI
errRonan Flippot; Yann-Alexandre Vano; Cécile Dalban; Benoit Beuselinck; Aude Fléchon; Maxime Meylan; Damien Pouessel; Antoine Bougoüin; Catherine Sautes-Fridman; Gwenaelle Gravis; Nathalie Chaput; Stéphane Oudard; Aude Desnoyer; Brigitte Laguerre; Salem Chouaib; Philippe Barthelemy; Delphine Borchiellini; Lucia Carril-Ajuria; Marine Gross-Goupil; Wolf-Herman Fridman; Lionnel Geoffrois; Frederic Rolland; Antoine Thiery-Vuillemin; Florence Joly; Sylvain Ladoire; Florence Tantot; Sylvie Chabaud; Bernard Escudier; Nathalie Rioux-Leclercq; Laurence Albiges
err分享
err收藏
Radiotherapy for penile cancers: 2025 update阴茎癌的放射治疗:2025年更新
err2025-11-01
err0
errOAAI
errLoos, Genevieve; Escande, Alexandre; Aziez, Sabrina; Marchesi, Vincent; Sargos, Paul; Terzilli, Mario; Latorzeff, Igor; Supiot, Stephane; Achard, Verane; Le Guevelou, Jennifer; Flechon, Aude; Hannoun-Levi, Jean-Michel; Chargari, Cyrus
err分享
err收藏
Abemaciclib plus abiraterone in patients with metastatic castration-resistant prostate cancer (CYCLONE 2): a randomised, double-blind, placebo-controlled, phase 3 trial阿贝西利布联合阿比特龙在转移性去势抵抗性前列腺癌患者中的研究(CYCLONE 2):一项随机、双盲、安慰剂对照、Ⅲ期临床试验
err2025-10-27
err0
PREAI
errMatthew Smith; Josep Piulats; Tilman Todenhöfer; Jae-Lyun Lee; José Arranz Arija; Laura Mazilu; Arun Azad; Teresa Alonso-Gordoa; Ursula McGovern; Atish Choudhury; Lisa Horvath; Dingwei Ye; Weiqing Han; Hiroyoshi Suzuki; Hiroji Uemura; Rana McKay; Steven Ades; Aude Fléchon; Christopher Pieczonka; Maria S Fernandes; Maarten Hulstijn; Andrew Lithio; Karim Nacerddine; Neeraj Agarwal
err分享
err收藏
Adjusting for abiraterone-prednisone cross-over in de novo metastatic castration-sensitive prostate cancer: a post-hoc analysis of the PEACE-1 trial调整阿比特龙-泼尼松交叉对原发转移性去势敏感前列腺癌的影响:PEACE-1试验的事后分析
err2025-09-27
err0
PREAI
errAdrien Rousseau; Maryam Karimi; Stefan Michiels; Guilhem Roubaud; Xavier Maldonado; Stephane Supiot; Ray McDermott; Aude Flechon; Bertrand Tombal; Philippe Ronchin; Dominik Berthold; Jean-François Berdah; Gabriel Kacso; Gwenaelle Gravis; Fabio Calabro; Sophie Tartas; Xavier Muracciole; Helene Ribault; Karim Fizazi; Stéphanie Foulon
err分享
err收藏
Association between drug-related cutaneous adverse events and survival outcomes in patients treated with enfortumab vedotin接受恩沃利单抗 vedotin 治疗的患者中,药物相关皮肤不良事件与生存结局的关联。
err2025-06-01
err0
errOAAI
errBelkaid, Samy; Ribereau-Gayon, Emmanuel; Chabaud, Sylvie; Anriot, Julien; Chalas, Thibald; Flechon, Aude; Boyle, Helen; Vinceneux, Armelle; Berard, Frederic; You, Benoit; Freyer, Gilles; Darnis, Sophie; Tartas, Sophie; Amini-Adle, Mona
err分享
err收藏
Enfortumab vedotin plus pembrolizumab versus chemotherapy in patients with previously untreated locally advanced or metastatic urothelial cancer (EV-302): patient-reported outcomes from an open-label, randomised, controlled, phase 3 study恩诺单抗维多汀联合帕博利珠单抗对比化疗在先前未经治疗的局部晚期或转移性尿路上皮癌患者中的疗效(EV-302):一项开放标签、随机对照、III期研究的患者报告结局
err2025-05-28
err0
PREAI
errShilpa Gupta; Yohann Loriot; Michiel S Van der Heijden; Jens Bedke; Begoña P Valderrama; Eiji Kikuchi; Aude Fléchon; Daniel Petrylak; Maria De Santis; Matthew D Galsky; Jae Lyun Lee; Umang Swami; Srikala S Sridhar; Ugo De Giorgi; Phoebe Wright; Vanessa Shih; Yi-Tsung Lu; Xuesong Guan; Ryan Dillon; Aditya Shetty; Blanca Homet Moreno; Jennifer L Beaumont; Intan Purnajo; Shauna McManus; Thomas Powles
err分享
err收藏
Prospective randomized phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer - results of the SUNNIFORECAST trial非透明细胞肾细胞癌中,伊匹木单抗/纳武利尤单抗对比标准护理的 prospective randomized phase-II trial - SUNNIFORECAST trial 的结果
err2025-04-01
err0
errOAAI
errL. Bergmann; L. Albiges; M. Ahrens; M. Gross-Goupil; E. Boleti; G. Gravis; A. Fléchon; M.-O. Grimm; J. Bedke; P. Barthélémy; D. Castellano; B. Mellado; P. Ivanyi; S. Rottey; A. Flörcken; C. Suarez; P. Maroto; V. Grünwald; S.F. Oosting; J. Kopecky; S. Zschäbitz; M. Boegemann; T. Buchler; G. Niegisch; P.J. Goebell; T. Waddell; F. Joly; F. Priou; M. Retz; S. Siemer; U. Zimmermann; D. Deckbar; I. Burkholder; A. Hartmann; J.B. Haanen
err分享
err收藏
Detection of potential complications in cancer survivors after chemotherapy and development of a regional care network: the PASCA feasibility study
err2025-03-04
err0
errOAAI
errBuono, Romain; Perol, Olivia; Djebali, Meyssane; Borja, Melodie; Abadie, Alicia; Morisset, Stephane; Michallet, Anne-Sophie; Flechon, Aude; Boyle, Helen; Nicolas-Virelizier, Emmanuelle; Rey, Philippe; Guillermin, Yann; Assaad, Souad; Belhabri, Amine; Lebras, Laure; Blay, Jean-Yves; Fervers, Beatrice; Michallet, Mauricette
err分享
err收藏
Assessment of bone mineral density in men with de novo metastatic castration-sensitive prostate cancer treated with or without abiraterone acetate plus prednisone in the PEACE-1 phase 3 trial评估接受或不接受阿比特龙醋酸盐联合泼尼松治疗的初始转移性去势敏感前列腺癌男性患者的骨矿物质密度:PEACE-1 III期试验
err2025-03-01
err1
PREAI
errRoubaud, Guilhem; Kostine, Marie; Mcdermott, Raymond S.; Bernard-Tessier, Alice; Maldonado, Xavier; Silva, Marlon; Flechon, Aude; Berthold, Dominik R.; Ronchin, Philippe; Tombal, Bertrand F.; Mourey, Loic; Gravis, Gwenaelle; Escande, Anne; Abadie-Lacourtoisie, Sophie; Maurina, Tristan; Climent, Miguel A.; Ribault, Helene; Bossi, Alberto; Foulon, Stephanie; Fizazi, Karim
err分享
err收藏
Real-world Study of Avelumab First-line Maintenance Treatment in Patients with Advanced Urothelial Carcinoma in France: Overall Results from the Noninterventional AVENANCE Study and Analysis of Outcomes by Second-line Treatment法国真实世界研究中avelumab作为一线维持治疗用于晚期尿路上皮癌患者的非干预性AVENANCE研究:总体结果及按二线治疗的结局分析
err2024-10-01
err0
PREAI
errPhilippe Barthélémy; Constance Thibault; Aude Fléchon; Marine Gross-Goupil; Eric Voog; Jean-Christophe Eymard; Christine Abraham; Matthieu Chasseray; Véronique Lorgis; Werner Hilgers; Aurélien Gobert; Sylvestre Le Moulec; Camille Simon; Emanuel Nicolas; Anne Escande; Damien Pouessel; Guillaume Mouillet; Constant Josse; Marie-Noelle Solbes; Prisca Lambert; Yohann Loriot
err分享
err收藏
Activity of Lutetium-177 Prostate-specific Membrane Antigen and Determinants of Outcomes in Patients with Metastatic Castration- resistant Prostate Cancer Previously Treated with Cabazitaxel: The PACAP Study先前接受卡巴他赛治疗的转移性去势抵抗性前列腺癌患者的177前列腺特异性膜抗原活性和预后决定因素: PACAP研究
err2024-10-01
err0
errOAAI
errFlippot, Ronan; Telli, Tugce; Velev, Maud; Flechon, Aude; De Vries-Brilland, Manon; Turpin, Leoa; Bergman, Andries; Turco, Fabio; Mahammedi, Hakim; Fendler, Wolfgang P.; Giraudet, Anne-Laure; Josset, Quentin; Montravers, Francoise; Vogel, Wouter; Gillessen, Silke; Vilei, Simona Berardi; Herrmann, Ken; Kryza, David; Paone, Gaetano; Hadaschik, Boris; Merlin, Charles; Dufour, Pierre-Alban; Bernard-Tessier, Alice; Naoun, Natacha; Patrikidou, Anna; Garcia, Camilo; Foulon, Stephanie; Pages, Arnaud; Fizazi, Karim
err分享
err收藏
Haematologic impact of [177Lu]Lu-PSMA-617 versus ARPI change in patients with metastatic castration-resistant prostate cancer in PSMAfore在PSMAfore研究中,[177Lu]Lu-PSMA-617与ARPI对转移性去势抵抗性前列腺癌患者血液学影响的变化比较
err2024-09-01
err0
PREAI
errChi, K. N.; Sartor, O.; Fizazi, K.; de Bono, J. S.; Shore, N. D.; Herrmann, K.; Castellano Gauna, D. E.; Piulats Rodriguez, J. M.; Flechon, A.; Wei, X. X.; Kim, H.; Schweizer, M.; Alanee, S.; Ghebremariam, S.; Hertelendi, M.; Morris, M. J.
err分享
err收藏
Efficacy of 177Lu-PNT2002 in PSMA-positive mCRPC following progression on an androgen-receptor pathway inhibitor (ARPI) (SPLASH)雄激素受体途径抑制剂 (ARPI) (SPLASH) 进展后,177Lu-PNT2002在PSMA阳性mCRPC中的疗效
err2024-09-01
err9
PREAI
errSartor, O.; Jiang, D. M.; Smoragiewicz, M.; Zibelman, M.; Flechon, A.; El-Haddad, G.; Abikhzer, G.; Saad, F.; Tutrone, R.; Tagawa, S. T.; Metser, U.; Calais, J.; Hansen, A. R.; Wu, W.; Jensen, J.; Trieu, C. R.; Fleshner, N.; Teslenko, I.; Provost, J-C. G.; Chi, K. N.
err分享
err收藏
177Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): a phase 3, randomised, controlled trial177Lu-PSMA-617与雄激素受体途径抑制剂治疗的变化对紫杉烷初治的进行性转移性去势抵抗性前列腺癌患者 (PSMAfore): 一项3期随机对照试验
errLANCET
IF88.5
err2024-09-01
err4
PREAI
errMorris, Michael J.; Castellano, Daniel; Herrmann, Ken; de Bono, Johann S.; Shore, Neal D.; Chi, Kim N.; Crosby, Michael; Piulats, Josep M.; Flechon, Aude; Wei, Xiao X.; Mahammedi, Hakim; Roubaud, Guilhem; Studentova, Hana; Nagarajah, James; Mellado, Begona; Montesa-Pino, Alvaro; Kpamegan, Euloge; Ghebremariam, Samson; Kreisl, Teri N.; Wilke, Celine; Lehnhoff, Katja; Sartor, Oliver; Fizazi, Karim
err分享
err收藏
A plain language summary of the TROPHY-U-01 study: sacituzumab govitecan use in people with locally advanced or metastatic urothelial cancer
err2024-06-05
err0
PREAI
errLoriot, Yohann; Kalebasty, Arash Rezazadeh; Flechon, Aude; Jain, Rohit K.; Gupta, Sumati; Bupathi, Manojkumar; Beuzeboc, Philippe; Palmbos, Phillip; Balar, Arjun, V; Kyriakopoulos, Christos E.; Pouessel, Damien; Sternberg, Cora N.; Tonelli, Julia; Sierecki, Mitch; Zhou, Huafeng; Grivas, Petros; Barthelemy, Philippe; Bangs, Rick; Tagawa, Scott T.
err分享
err收藏
err分享
err收藏
TROPHY-U-01, a phase II open-label study of sacituzumab govitecan in patients with metastatic urothelial carcinoma progressing after platinumbased chemotherapy and checkpoint inhibitors: updated safety and efficacy outcomesTROPHY-U-01,sacituzumab govitecan用于铂化疗和检查点抑制剂后进展的转移性尿路上皮癌患者的II期开放标签研究: 更新的安全性和有效性结果
err2024-04-01
err17
errOAAI
errLoriot, Y.; Petrylak, D. P.; Kalebasty, A. Rezazadeh; Flechon, A.; Jain, R. K.; Gupta, S.; Bupathi, M.; Beuzeboc, P.; Palmbos, P.; V. Balar, A.; Kyriakopoulos, C. E.; Pouessel, D.; Sternberg, C. N.; Tonelli, J.; Sierecki, M.; Zhou, H.; Grivas, P.; Barthelemy, P.; Tagawa, S. T.
err分享
err收藏
Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial CancerEnfortumab Vedotin和Pembrolizumab在未经治疗的晚期尿路上皮癌中的应用
err2024-03-07
err153
PREAI
errPowles, T.; Valderrama, B. P.; Gupta, S.; Bedke, J.; Kikuchi, E.; Hoffman-Censits, J.; Iyer, G.; Vulsteke, C.; Park, S. H.; Shin, S. J.; Castellano, D.; Fornarini, G.; Li, J. R.; Guemues, M.; Mar, N.; Loriot, Y.; Flechon, A.; Duran, I; Drakaki, A.; Narayanan, S.; Yu, X.; Gorla, S.; Moreno, B. Homet; van der Heijden, M. S.
err分享
err收藏